Value proposition

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE

As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners:
- a genuine end-to-end development and manufacturing solution
- that facilitates and accelerates drugs availability for patients.

Our main activities are:

1) CDMO
BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices.
Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder in vials, nasal sprays, creams, tablets...).
Our CDMO covers all steps of development and production from manufacturing of clinical or commercial batches to analytical services, assistance supply with procurement of raw materials, packaging and serialisation.

2) Marketing Authorisation Holder of a portfolio of Rx, OTC and food supplements sold in Belgium and Luxembourg, mainly in Ophtalmology and Dermatology.

3) Development of innovative drug delivery systems such as our patented MMCR platform (MMCR: multi-layer micro-particle controlled release). This technology innovation enables the development of a controlled release syrup, which is a real breakthrough to help patients with swallowing impairments (paediatric and elderly).


CDMO, Licensing, Services analytiques, Développement galénique, MMCR, Production EU-GMP, Médicaments, Dispositifs Médicaux, Compléments alimentaires, Produits humains, and Produits vétérinaires